Answers are grounded in this paper and cite their sources.
This research demonstrates altered brain activity in patients with paroxysmal kinesigenic dyskinesia, suggesting PRRT2 mutations may influence clinical symptoms and brain function.
Motivation: Paroxysmal kinesigenic dyskinesia(PKD) with PRRT2 mutations presents different clinical features, yet the underlying neurobiological mechanisms remain to be elucidated. Goal(s): Our goal was to clarify brain activity patterns in PKD patients with and without PRRT2 mutations. Approach: Besides health controls, We collected resting-state functional magnetic resonance imaging (rs-fMRI) data from PKD patients with PRRT2 mutations and PKD patients without PRRT2 mutations. Based on fractional amplitude of low-frequency fluctuations (fALFF), we explored group differences and clinical correlations. Results: Significant differences of fALFF were identified among participants in several brain regions, including parahippocampal gyrus, superior frontal gyrus, lingual gyrus and cerebellum. Impact: Altered brain activity in PKD patients based on fALFF could help further understand the neuropathophysiological mechanisms of the disease and search for objective markers.
No takes yet. Share an insight, caveat, or question.
Song et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: